Rochester Drug Co-Operative and two of its chief executives were charged this week for conspiracy and suspicious pharmaceutical orders, as reported on by RochesterFirst.com. The pharmaceutical company agreed to a $20 million settlement to be paid over five years, with three years of compliance monitoring. The article includes commentary from U.S. Attorney Geoffrey S. Berman:
“This prosecution is the first of its kind: executives of a pharmaceutical distributor and the distributor itself have been charged with drug trafficking, trafficking the same drugs that are fueling the opioid epidemic that is ravaging this country. Our office will do everything in its power to combat this epidemic, from street-level dealers to the executives who illegally distribute drugs from their boardrooms.”
Learn more about the case here, or find an opioid addiction treatment center in Rochester.